|
Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
|---|---|
| Feb 29, 2024 |
print number 1393a |
| Feb 29, 2024 |
amend and recommit to insurance |
| Jan 03, 2024 |
referred to insurance |
| Jan 17, 2023 |
referred to insurance |
Assembly Bill A1393A
2023-2024 Legislative Session
Sponsored By
ROSENTHAL L
Current Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Bill Amendments
co-Sponsors
Angelo Santabarbara
2023-A1393 - Details
2023-A1393 - Bill Text download pdf
S T A T E O F N E W Y O R K
________________________________________________________________________
1393
2023-2024 Regular Sessions
I N A S S E M B L Y
January 17, 2023
___________
Introduced by M. of A. L. ROSENTHAL -- read once and referred to the
Committee on Insurance
AN ACT to amend the insurance law, in relation to requiring health
insurers to provide coverage for opioid antagonists and devices
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Subsection (i) of section 3216 of the insurance law is
amended by adding a new paragraph 39 to read as follows:
(39) (A) (I) EVERY POLICY WHICH PROVIDES COVERAGE FOR PRESCRIPTION
DRUGS SHALL INCLUDE COVERAGE FOR AT LEAST ONE OPIOID ANTAGONIST AND
DEVICE. PRIOR AUTHORIZATION MAY BE REQUIRED FOR NON-GENERIC FORMS OF
OPIOID ANTAGONISTS AND DEVICES.
(II) AS USED IN THIS PARAGRAPH "OPIOID ANTAGONIST AND DEVICE" MEANS A
DRUG APPROVED BY THE FOOD AND DRUG ADMINISTRATION THAT, WHEN ADMINIS-
TERED, NEGATES OR NEUTRALIZES IN WHOLE OR IN PART THE PHARMACOLOGICAL
EFFECTS OF AN OPIOID IN THE BODY. "OPIOID ANTAGONIST" SHALL BE LIMITED
TO NALOXONE AND OTHER MEDICATIONS APPROVED BY THE DEPARTMENT OF HEALTH
FOR SUCH PURPOSE.
(B) THE COVERAGE MANDATED BY THIS PARAGRAPH SHALL INCLUDE OPIOID
ANTAGONISTS PRESCRIBED OR DISPENSED VIA STANDING ORDER OR COLLABORATIVE
PRACTICE AGREEMENT INTENDED FOR USE ON PATIENTS OTHER THAN THE INSURED.
(C) COVERAGE PROVIDED UNDER THIS PARAGRAPH MAY BE SUBJECT TO ANNUAL
DEDUCTIBLES AND CO-INSURANCE AS DEEMED APPROPRIATE BY THE SUPERINTENDENT
AND THAT ARE CONSISTENT WITH THOSE IMPOSED ON OTHER BENEFITS WITHIN A
GIVEN POLICY.
§ 2. Subsection (l) of section 3221 of the insurance law is amended by
adding a new paragraph 7-c to read as follows:
(7-C) (A) (I) EVERY POLICY WHICH PROVIDES COVERAGE FOR PRESCRIPTION
DRUGS SHALL INCLUDE COVERAGE FOR AT LEAST ONE OPIOID ANTAGONIST AND
DEVICE. PRIOR AUTHORIZATION MAY BE REQUIRED FOR NON-GENERIC FORMS OF
OPIOID ANTAGONISTS AND DEVICES.
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD01316-02-3
co-Sponsors
Angelo Santabarbara
2023-A1393A (ACTIVE) - Details
2023-A1393A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K
________________________________________________________________________
1393--A
2023-2024 Regular Sessions
I N A S S E M B L Y
January 17, 2023
___________
Introduced by M. of A. L. ROSENTHAL, SANTABARBARA -- read once and
referred to the Committee on Insurance -- recommitted to the Committee
on Insurance in accordance with Assembly Rule 3, sec. 2 -- committee
discharged, bill amended, ordered reprinted as amended and recommitted
to said committee
AN ACT to amend the insurance law, in relation to requiring health
insurers to provide coverage for opioid antagonists and devices
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Subsection (i) of section 3216 of the insurance law is
amended by adding a new paragraph 39 to read as follows:
(39) (A) (I) EVERY POLICY WHICH PROVIDES COVERAGE FOR PRESCRIPTION
DRUGS SHALL INCLUDE COVERAGE FOR AT LEAST ONE OPIOID ANTAGONIST AND
DEVICE. PRIOR AUTHORIZATION MAY BE REQUIRED FOR NON-GENERIC FORMS OF
OPIOID ANTAGONISTS AND DEVICES.
(II) AS USED IN THIS PARAGRAPH "OPIOID ANTAGONIST AND DEVICE" MEANS A
DRUG APPROVED BY THE FOOD AND DRUG ADMINISTRATION THAT, WHEN ADMINIS-
TERED, NEGATES OR NEUTRALIZES IN WHOLE OR IN PART THE PHARMACOLOGICAL
EFFECTS OF AN OPIOID IN THE BODY. "OPIOID ANTAGONIST" SHALL BE LIMITED
TO NALOXONE AND OTHER MEDICATIONS APPROVED BY THE DEPARTMENT OF HEALTH
FOR SUCH PURPOSE.
(B) THE COVERAGE MANDATED BY THIS PARAGRAPH SHALL INCLUDE OPIOID
ANTAGONISTS PRESCRIBED OR DISPENSED VIA STANDING ORDER OR COLLABORATIVE
PRACTICE AGREEMENT INTENDED FOR USE ON PATIENTS OTHER THAN THE INSURED.
(C) A POLICY SHALL NOT IMPOSE A DEDUCTIBLE, CO-INSURANCE, CO-PAYMENT,
OR ANY OTHER COST-SHARING REQUIREMENT ON SUCH COVERAGE PROVIDED PURSUANT
TO THIS PARAGRAPH.
§ 2. Subsection (l) of section 3221 of the insurance law is amended by
adding a new paragraph 7-c to read as follows:
(7-C) (A) (I) EVERY POLICY WHICH PROVIDES COVERAGE FOR PRESCRIPTION
DRUGS SHALL INCLUDE COVERAGE FOR AT LEAST ONE OPIOID ANTAGONIST AND
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD01316-03-4
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.